Growth hormone-releasing peptide-biotin conjugate stimulates myocytes differentiation through insulin-like growth factor-1 and collagen type I
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Based on the potential beneficial effects of growth hormone releasing peptide (GHRP)-6 on muscle functions, a newly synthesized GHRP-6-biotin conjugate was tested on cultured myoblast cells. Increased expression of myogenic marker proteins was observed in GHRP-6-biotin conjugate-treated cells. Additionally, increased expression levels of insulin-like growth factor- 1 and collagen type I were observed. Furthermore, GHRP- 6-biotin conjugate-treated cells showed increased metabolic activity, as indicated by increased concentrations of energy metabolites, such as ATP and lactate, and increased enzymatic activity of lactate dehydrogenase and creatine kinase. Finally, binding protein analysis suggested few candidate proteins, including desmin, actin, and zinc finger protein 691 as potential targets for GHRP6-biotin conjugate action. These results suggest that the newly synthesized GHRP-6-biotin conjugate has myogenic stimulating activity through, at least in part, by stimulating collagen type I synthesis and several key proteins. Practical applications of the GHRP-6-biotin conjugate could include improving muscle condition.
Abstract
Based on the potential beneficial effects of growth hormone releasing peptide (GHRP)-6 on muscle functions, a newly synthesized GHRP-6-biotin conjugate was tested on cultured myoblast cells. Increased expression of myogenic marker proteins was observed in GHRP-6-biotin conjugate-treated cells. Additionally, increased expression levels of insulin-like growth factor- 1 and collagen type I were observed. Furthermore, GHRP- 6-biotin conjugate-treated cells showed increased metabolic activity, as indicated by increased concentrations of energy metabolites, such as ATP and lactate, and increased enzymatic activity of lactate dehydrogenase and creatine kinase. Finally, binding protein analysis suggested few candidate proteins, including desmin, actin, and zinc finger protein 691 as potential targets for GHRP6-biotin conjugate action. These results suggest that the newly synthesized GHRP-6-biotin conjugate has myogenic stimulating activity through, at least in part, by stimulating collagen type I synthesis and several key proteins. Practical applications of the GHRP-6-biotin conjugate could include improving muscle condition.
참고문헌 (31)
- Makrantonaki E, "Skin and brain age together: The role of hormones in the ageing process", Exp Gerontol, 45, pp.801~813 (2010)
- Zouboulis CC, "Hormonal therapy of intrinsic aging", Rejuvenation Res, 15, pp.302~312 (2012)
- DeVita RJ, "Small molecule mimetics of GHRP-6", Expert Opin Investig Drugs, 6, pp.1839~1843 (1997)
- Micic D, "Growth hormone secretagogues:the clinical future", Horm Res, 51(3), pp.29~33 (1999)
- Makrantonaki E, "The skin as a mirror of the aging process in the human organism--state of the art and results of the aging research in the German National Genome Research Network 2(NGFN-2)", Exp Gerontol, 42, pp.879~886 (2007)
- Florini JR, "Growth hormone and the insulin-like growth factor system in myogenesis", Endocr Rev, 17, pp.481~517 (1996)
- Yi JS, "MG53-induced IRS-1ubiquitination negatively regulates skeletal myogenesis and insulin signalling", Nat Commun, 4, pp.2354~ (2013)
- Paneda C, "Growth hormone-releasing peptide-6 inhibits cerebellar cell death in aged rats", Neuroreport, 14, pp.1633~1635 (2003)
- Smith RG, "Development of growth hormone secretagogues", Endocr Rev, 26, pp.346~360 (2005)
- Granado M, "Insulin and growth hormone-releasing peptide-6(GHRP-6)have differential beneficial effects on cell turnover in the pituitary, hypothalamus and cerebellum of streptozotocin(STZ)-induced diabetic rats", Mol Cell Endocrinol, 337, pp.101~113 (2011)
- Berlanga J, "Growth-hormone-releasing peptide 6(GHRP6)prevents oxidant cytotoxicity and reduces myocardial necrosis in a model of acute myocardial infarction", Clin Sci (Lond), 112, pp.241~250 (2007)
- Pontiroli AE, "Peptide hormones: Review of current and emerging uses by nasal delivery", Adv Drug Deliv Rev, 29, pp.81~87 (1998)
- Fleisher D, "Topical delivery of growth hormone releasing peptide using liposomal systems: an in vitro study using hairless mouse skin", Life Sci, 57, pp.1293~1297 (1995)
- Charge SB, "Cellular and molecular regulation of muscle regeneration", Physiol Rev, 84, pp.209~238 (2004)
- Smith CK 2nd, "Temporal expression of myogenic regulatory genes during activation, proliferation, and differentiation of rat skeletal muscle satellite cells", J Cell Physiol, 159, pp.379~385 (1994)
- Asakura A, "Muscle satellite cells are multipotential stem cells that exhibit myogenic, osteogenic, and adipogenic differentiation", Differentiation, 68, pp.245~253 (2001)
- Florini JR, "Hormones, growth factors, and myogenic differentiation", Annu Rev Physiol, 53, pp.201~216 (1991)
- Lee CS, "TRIM72 negatively regulates myogenesis via targeting insulin receptor substrate-1", Cell Death Differ, 17, pp.1254~1265 (2010)
- Frago LM, "Growth hormone(GH)and GH-releasing peptide-6 increase brain insulin-like growth factor-I expression and activate intracellular signaling pathways involved in neuroprotection", Endocrinology, 143, pp.4113~4122 (2002)
- Frago LM, "Growth hormone-releasing peptide-6 increases insulinlike growth factor-I mRNA levels and activates Akt in RCA-6cells as a model of neuropeptide Y neurones", J Neuroendocrinol, 17, pp.701~710 (2005)
- Zhou S, "Increased collagen synthesis rate during wound healing in muscle", PLoS One, 8, pp.e58324~ (2013)
- Bonaldo P, "Collagen VI deficiency induces early onset myopathy in the mouse: an animal model for Bethlem myopathy", Hum Mol Genet, 7, pp.2135~2140 (1998)
- Takano H, "The Rho family G proteins play a critical role in muscle differentiation", Mol Cell Biol, 18, pp.1580~1589 (1998)
- Schwander M, "Beta1 integrins regulate myoblast fusion and sarcomere assembly", Dev Cell, 4, pp.673~685 (2003)
- Paulin D, "Desmin : a major intermediate filament protein essential for the structural integrity and function of muscle", Exp Cell Res, 301, pp.1~7 (2004)
- Li Z, "Desmin is essential for the tensile strength and integrity of myofibrils but not for myogenic commitment, differentiation, and fusion of skeletal muscle", J Cell Biol, 139, pp.129~144 (1997)
- Li H, "Inhibition of desmin expression blocks myoblast fusion and interferes with the myogenic regulators MyoD and myogenin", J Cell Biol, 124, pp.827~841 (1994)
- Lokireddy S, "Identification of atrogin-1-targeted proteins during the myostatin-induced skeletal muscle wasting", Am J Physiol Cell Physiol, 303, pp.512~529 (2012)
- Cohen S, "Ubiquitylation by Trim32 causes coupled loss of desmin, Z-bands, and thin filaments in muscle atrophy", J Cell Biol, 198, pp.575~589 (2012)
- Hong J, "Mitochondrial complex I deficiency enhances skeletal myogenesis but impairs insulin signaling through SIRT1 inactivation", J Biol Chem, 289, pp.20012~20025 (2014)
- Kim BW, "Mitochondrial oxidative phosphorylation system is recruited to detergent-resistant lipid rafts during myogenesis", Proteomics, 10, pp.2498~2515 (2010)
